Search Within

Vincent Miller

Formats
  1. Journal Article (152)
  2. Meeting Abstract (114)
  3. Book Section (2)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (207)
  2. Solid Tumor Oncology Division (197)
  3. Thoracic Oncology (189)
  4. Department of Pathology and Laboratory Medicine (71)
  5. GSK Faculty (67)
  6. Human Oncology and Pathogenesis Program (64)

More Groups

People
  1. Mark Kris (172)
  2. Gregory Riely (79)
  3. William Pao (65)
  4. Marc Ladanyi (59)
  5. Christopher Azzoli (46)
  6. Maureen Zakowski (46)

More People

Years
  1. 2019 (1)
  2. 2017 (2)
  3. 2016 (1)
  4. 2015 (3)
  5. 2014 (5)
  6. 2013 (4)

More Years

Publications
  1. Journal of Clinical Oncology (80)
  2. Clinical Cancer Research (39)
  3. Journal of Thoracic Oncology (24)
  4. Seminars in Oncology (13)
  5. Cancer (10)
  6. Cancer Chemotherapy and Pharmacology (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (80)
  2. American Association for Cancer Research (57)
  3. Elsevier Inc. (38)
  4. Elsevier Science, Inc. (11)
  5. Springer (10)
  6. Wiley Blackwell (10)

More Publishers

Results (270)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Do molecular diagnostics add to clinical characteristics in selecting patients for gefitinib treatment? Commentary
    Journal Article

    Janjigian, Y. Y.; Miller, V. A.
    Nature Clinical Practice Oncology (2008)

    Fulltext@MSK | Save
  • Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma
    Journal Article

    Bean, J.; Riely, G. J.; Balak, M.; Marks, J. L.; Ladanyi, M.; Miller, V. A.; Pao, W.
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • A randomized phase II trial comparing pulsed erlotinib before or after carboplatin and paclitaxel in patients with stage IIIB or IV non-small cell lung cancer
    Meeting Abstract

    Riely, G. J.; Rudin, C. M.; Kris, M. G.; Senturk, E.; Azzoli, C. G.; Brahmer, J.; Fogle, M.; Ginsberg, M.; Miller, V. A.; Rizvi, N. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase II study of the efficacy and safety of intravenous (IV) AVE0005 (VEGF Trap) given every 2 weeks in patients (Pts) with platinum- and erlotinib- resistant adenocarcinoma of the lung (NSCLA)
    Meeting Abstract

    Massarelli, E.; Miller, V. A.; Leighl, N. B.; Rosen, P. J.; Albain, K. S.; Hart, L. L.; Melnyk, O.; Sternas, L.; Ackerman, J.; Herbst, R. S.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Smoking history and frequency of somatic KRAS mutations in adenocarcinoma of the lung
    Meeting Abstract

    Miller, V. A.; Riely, G. J.; Kris, M. G.; Rosenbaum, D.; Marks, J.; Li, A.; Chitale, D.; Nafa, K.; Pao, W.; Ladanyi, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of the antifolate pralatrexate given with vitamin B(12) and folic acid supplementation in patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Azzoli, C. G.; Krug, L.; Miller, V.; Bekele, S.; Tyson, L.; Dunne, M.; Huntington, M.; Saunders, M.; Kris, M. G.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A phase II study of XL647 in patients with non-small cell lung cancer (NSCLC) enriched for presence of EGFR mutations
    Meeting Abstract

    Rizvi, N.; Kris, M.; Miller, V.; Krug, L.; Bekele, S.; Dowlati, A.; Rowland, K.; Tonda, M.; Mitchell, B.; Ruckdeschels, J.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • EGFR mutations in lung adenocarcinomas: Clinical testing experience in 334 consecutive cases and relationship to EGFR gene copy number and immunohistochemical expression
    Meeting Abstract

    Li, A. R.; Chitale, D.; Riely, G. J.; Pao, W.; Ma, Y.; Zheng, T.; Miller, V. A.; Zakowski, M. F.; Rusch, V.; Kris, M. G.; more...
    Journal of Molecular Diagnostics (2007)

    Fulltext@MSK | Save
  • Phase I study of the anitfolate pralatrexate given with vitamin B12 and folic acid supplementation in patients with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    James, L. P.; Azzoli, C. G.; Krug, L. M.; Miller, V.; Tripathi, P.; Subzwari, S.; Tyson, L. B.; Dunne, M.; Huntington, M. F.; Saunders, M. E.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • A pilot phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung
    Meeting Abstract

    Haura, E. B.; Larson, T. G.; Stella, P. J.; Bazhenova, L.; Miller, V. A.; Cohen, R. B.; Eisenberg, P. D.; Selaru, P.; Wilner, K. D.; Ricart, A. D.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save